Metraipolis › archive › dc_03e7524fbb95

Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011-2022: a retrospective open cohort study — Europe PMC PMID:40888243

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40888243
DOI
10.5694/mja2.70026
License (as archived)
solo-consultazione
Archived
2026-11-10T05:44:12.479Z
SHA-256 of the archived text
af0b50e4bf42016f53f17cb0e872e080e78c40e561252cd746536a6e28d993d0
Stable URL of this page
https://metraipolis.com/documento/dc_03e7524fbb95

How to cite

Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011-2022: a retrospective open cohort study — Europe PMC PMID:40888243 — Europe PMC (en), https://europepmc.org/article/MED/40888243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03e7524fbb95 (Metraipolis archive dc_03e7524fbb95, sha256 af0b50e4bf42016f53f17cb0e872e080e78c40e561252cd746536a6e28d993d0)
BibTeX
@misc{dc03e7524fbb95,
  title = {Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011-2022: a retrospective open cohort study — Europe PMC PMID:40888243},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40888243},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03e7524fbb95; sha256 af0b50e4bf42016f53f17cb0e872e080e78c40e561252cd746536a6e28d993d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40888243. Agents can read the archived copy with the MCP tool read_document.